Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia in Patients Treated With Anti-CD20 Monoclonal Antibodies-Reference-Cited by-同舟云学术

Persistent Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia in Patients Treated With Anti-CD20 Monoclonal Antibodies

Published:2023-09-15 Issue:10 Volume:10 Page:
ISSN:2328-8957
Container-title:Open Forum Infectious Diseases
language:en
Short-container-title:

Author:

Furie Nadav¹²^ORCID,Mandelboim Michal²³,Zuckerman Neta²³,Belkin Ana⁴⁵,Seluk Lior¹²,Shafran Inbal¹²,Mass Ronen¹,Levy Liran¹²,Chatterji Sumit¹,Baltaxe Erik¹²,Peled Michael¹²,Shulimzon Tiberiu¹,Avigdor Abraham²⁶,Amit Sharon⁷,Onn Amir¹²,Marom Edith M²⁸,Rahav Galia²⁵^ORCID,Segel Michael J¹²

Affiliation:

1. Institute of Pulmonology, Sheba Medical Center , Tel Hashomer , Israel

2. Sackler Faculty of Medicine, Tel-Aviv University , Tel Aviv , Israel

3. Central Virology Laboratory, Public Health Services, Ministry of Health and Sheba Medical Center , Tel-Hashomer , Israel

4. Internal Medicine D, Sheba Medical Center , Tel Hashomer , Israel

5. Infectious Diseases Unit, Sheba Medical Center , Tel Hashomer , Israel

6. Division of Hematology and Bone-Marrow Transplantation, Sheba Medical Center , Ramat Gan , Israel

7. Microbiology Laboratory, Sheba Medical Center , Tel Hashomer , Israel

8. Department of Diagnostic Radiology, Sheba Medical Center , Tel Hashomer , Israel

Abstract

Abstract We report 8 cases of persistent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pneumonia in patients previously treated with anti-CD20 monoclonal antibodies. Polymerase chain reaction of nasopharyngeal swabs for SARS-CoV-2 was negative in most cases; viral cell cultures confirmed that viable SARS-Co-2 virus was present. Four patients were treated with anti-SARS-CoV-2 hyperimmune globulins with rapid resolution of disease.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Oncology

Link

https://academic.oup.com/ofid/advance-article-pdf/doi/10.1093/ofid/ofad464/51607775/ofad464.pdf

Reference11 articles.

1. Case study: prolonged infectious SARS-CoV-2 shedding from an asymptomatic immunocompromised individual with cancer;Avanzato;Cell,2020

2. Persistence and evolution of SARS-CoV-2 in an immunocompromised host;Hoi;N Engl J Med,2020

3. Persistent COVID-19 in an immunocompromised patient temporarily responsive to two courses of remdesivir therapy;Helleberg;J Infect Dis,2020

4. Persistent COVID19 pneumonia and failure to develop anti-SARS-CoV-2 antibodies during rituximab maintenance therapy for follicular lymphoma;Yasuda;Clin Lymphoma Myeloma Leuk,2020

5. Real time PCR and culture-based virus isolation test in clinically recovered patients: is the subject still infectious for SARS-CoV2?;Manzulli;J Clin Med,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Obinutuzumab/rituximab/tozinameran;Reactions Weekly;2024-08-10

2. Persistent COVID-19 in immunocompromised patients—Israeli society of infectious diseases consensus statement on diagnosis and management;Clinical Microbiology and Infection;2024-08

3. A Descriptive, Retrospective Analysis of COVID-19 Passive Antibody Therapy and Its Effects on Morbidity and Mortality in Patients Receiving B-Cell-Depleting Therapies;Diseases;2024-02-06